Contact Us | Directions | Referring a Patient

A leading comprehensive brain tumor program, using molecular diagnostic, gene expression analysis,
cutting edge clinical trials and advanced medical informatics to customize treatment plans for cancer patients.
 Latest Headlines
Kilt event to raise brain tumor awareness
Wed, 04 May 2016 15:56:42 GMT (Northeast Mississippi Daily Journal)
As Concord 7th grader tries to recover from brain tumor, community raises $15000 in 2 days
Wed, 04 May 2016 19:22:15 GMT (NH1 News)
WCU chancellor has surgery at Duke after brain tumor diagnosis
Tue, 03 May 2016 21:31:34 GMT (WLOS)
Doctors Treat Girl's Brain Tumor With Polio Virus
Wed, 04 May 2016 14:12:30 GMT (Opposing Views)
Two people, one brain tumor: After battling the disease for more than a decade, Chicago couple vows to find a cure ...
Tue, 03 May 2016 20:13:51 GMT (PR Newswire (press release))
Teen's brain tumor recovery drives Novi family
Tue, 03 May 2016 09:04:00 GMT (
Belgian Pediatric Oncology startup Recruits for Brain Tumor Trial
Tue, 03 May 2016 06:00:27 GMT ( (blog))
Wish granted: 4-year-old who had brain tumor gets to build like his dad
Fri, 29 Apr 2016 20:24:48 GMT (Columbus Dispatch)
Jadudi diagnosed with second brain tumor months after successful operation
Tue, 03 May 2016 12:18:14 GMT (The Star, Kenya)
National Brain Tumor Society's Annual "Head to the Hill" Floods the Halls of Congress with Brain Tumor Advocates
Tue, 03 May 2016 17:19:02 GMT (Marketwired (press release))

* Headlines are from industry sponsored news wires, medical journals and established news organizations from around the world . Please consider the source of the content when viewing the story.
Dani Saleh Brain Cancer Research Fund at UCLA

The Dani Saleh Brain Cancer Research Fund supports the brain cancer research collaboration between Dr. Timothy Cloughesy and Dr. Stan Nelson. This fund will directly support the work and training of a research fellow in Dr. Stan Nelson’s lab.

Dr. Nelson is Professor and Vice Chair of Human Genetics and Professor of Psychiatry at the David Geffen School of Medicine at UCLA.

UCLA Neuro-Oncology & SiliconMED Launch Online Tool Correlating Gene Expression Levels with Overall Survival of Brain Cancer Patients

Genomic analysis is a powerful new tool permitting unprecedented insights into how brain tumors form and has been enabled primarily through microarray technology., a new web based tool, is aiming to help clinicians and researchers take the massive amount of data created by microarrays and better visualize gene expression levels and how they relate to the overall survival of brain cancer patients.

Most Popular
. Clinical Trials
. Probe Set Analyzer
. Our Team
. Brain Tumor Translational Resource
. Art of the Brain
. Personalized Medicine using Targeted Molecular Therapy
. Online Giving
. How our Glioblastoma Multiforme Patients Perform
Neuro-Oncology on Facebook

Spring/Summer 2014
UCLA Neuro-Oncology : Breakthroughs Spotlighting new discovery in brain cancer research.

It is time to include patients with brain tumors in phase I trials in oncology.
J Clin Oncol.

Graded functional diffusion map-defined characteristics of apparent diffusion coefficients predict overall survival in recurrent glioblastoma treated with bevacizumab.
Neuro Oncol.

Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma.
Neuro Oncol.

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol.

Phase II study of aflibercept in recurrent malignant glioma: a north american brain tumor consortium study.
J Clin Oncol.

All Information content hearof is designed for educational purposes only and is not for the purpose of rendering medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. Any specific questions you may have regarding an individual's medical condition should be directed to the individual's primary care physician or other attending physician. In addition, if you have or suspect you may have a health problem, you should consult your health care provider.

Portions Copyright (Search, Chart, Content Publishing Tools, Photography, ProviderIQ) 1998-2016 SiliconMED North America

ProviderIQ is a registered trademark of SiliconMED North America and used by permission.

Copyright © 2016 UCLA Neuro-Oncology Program | Timothly Cloughesy MD; Director
All Rights Reserved.

[Content Published:5/4/2016 11:23:03 PM PST]